Psychedelic Business Roundup- Key Psychedelic Industry Leader Joins The NASDAQ

May 12, 2021- This week's Psychedelic Business News Round Up's top stories include: - MindMed Now Listed On The Nasdaq - Psychedelic-Assisted Therapy Shows Benefits In Treating Depression Related to Childhood Abuse - Atai Life Sciences looks…
Texas Senate Approves Psychedelic Research Legislation Aimed at Military Veterans

Texas Senate Approves Psychedelic Research Legislation Aimed at Military Veterans

Texas has moved closer to legal psychedelic research for PTSD military veterans after the state senate approved the legislation.
Enveric Biosciences Acquires Psychedelic Drug Discovery Platform MagicMed Industries

Enveric Biosciences Acquires Psychedelic Drug Discovery Platform MagicMed Industries

Cannabis-focused Enveric Biosciences will acquire Canadian psychedelic drug discovery platform MagicMed Industries.
California Bill Decriminalizing Psychedelics Moves Closer to Full Senate Vote

California Bill Decriminalizing Psychedelics Moves Closer to Full Senate Vote

California legislation aimed at decriminalizing psychedelics is moving closer to a full Senate vote that could make it the 2nd state to pass such a measure.

Industry NEWS: The GOOD, The BAD, And The UGLY / New Psychedelic Studies, Legalization Bills & MORE!

Hey guys! In this week’s general industry news, we’ll cover some interesting developments. Some are probably going to make some of our viewers turn away from this week’s episode as they discover some pretty “depressing” statistics about North America’s current mental state. However, for those who stick around, you might end up finding that there might be a light at the end of the tunnel as you discover that psilocybin’s benefits might be extended to treat certain Enjoy! Links: Psilocybin & Migraines: https://www.psypost.org/2021/05/a-single-dose-of-psilocybin-has-a-lasting-therapeutic-effect-on-migraine-headache-according-to-a-new-placebo-controlled-study-60793 Increased depression in North America: https://www.meetfieldtrip.com/news/news-details/2021/Canadians-Are-Not-OK-83-of-Canadians-Report-One-Or-More-Symptoms-of-Depression-With-Many-Turning-To-Substances-To-Cope-With-Negative-Emotions-During-COVID-19-Pandemic-According-to-Field-Trip-Healths-First-Annual-State-of-Mind-Survey/default.aspx https://www.meetfieldtrip.com/news/news-details/2021/More-than-80-of-Americans-report-one-or-more-symptoms-of-depression-and-many-have-turned-to-substances-to-cope-with-negative-emotions-during-COVID-19-Pandemic-according-to-Field-Trip-Healths-First-Annual-State-of-Mind-Survey/default.aspx Opioid Overdose In Ontario: https://www.cp24.com/news/opioid-overdose-deaths-up-75-per-cent-in-ontario-during-covid-19-pandemic-new-report-1.5434080 FDA Greenlights Ketamine: https://psychedelicspotlight.com/ketamine-study-parkinsons-disease-treatment/ California Bill to Decriminalize Psychedelics Passes Senate Floor: https://www.marijuanamoment.net/california-bill-to-legalize-possession-of-psychedelics-heads-to-senate-floor-after-committee-action/ Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news! Follow us on social media! 🙌 Instagram: @thepsychedelicinvestor Email: thepsychedelicinvestor@gmail.com Facebook: @thepsychedelicinvestor Music: www.bensound.com Video editing: @themyaholy https://benzinga.grsm.io/jameshallifax1834 https://benzinga.grsm.io/thepsychedelicinvestor DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change. #MindMed #PsychedelicStocks #PsychedelicIndustry
Psychedelic Passage Bridges Gap Between Guide and Journeyer

Psychedelic Passage Bridges Gap Between Guide and Journeyer

There’s a lot to ensuring a safe psychedelic trip. Take the wrong dose, be in the wrong setting, or not have the right person beside you as you go through the experience—whether it’s your first time or your hundredth—can be risky.  But…
Psychedelic Business Spotlight: May 21, 2021

Psychedelic Business Spotlight: May 21, 2021

This week in psychedelic business news: Therapists cleared to try MDMA, alternative medicine guru promotes psychedelic therapy, and the Swiss green-light new mescaline study. On the heels of the recently released trial data showing how MDMA-assisted…

MindMed: What Does The Future Hold? ( MMED/ MNMD )

Hey guys! Today, we'll cover Part 2 of our discussion on MindMed's (MMED / MNMD / MMQ) conference call. In the previous episode, we talked about the progress MindMed has made up until this point, MindMed's mission, talent Acquisition, and the progress of their clinical trials. In today's episode, we will take a more futuristic approach and examine the future plans discussed in MindMed's Q1 conference call. We will cover topics such as: A. Where is MindMed going? B. What is MindMed 2.0? C. What will MindMed in 3 years time look like as compared to now? Over the next several years, we expect 4 transformations to occur. 1. MindMed’s transition to a tech company, from a pharmaceuticals company; 2. The shift from classic psychedelics like LSD to “next generation” patent protected substances; 3. Reorientation away from one size fits all medical solutions towards personalized medicine; 4. Finding Partnerships with major pharmaceutical companies. Timestamps: 0:00 - Intro 2:16 - MindMed transitioning to a tech company 7:14 -Next-gen shift 12:11 - Personalized medicine 13:59 - Partnerships Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news! Follow us on social media! 🙌 Instagram: @psychedelicinvestor Email: thepsychedelicinvestor@gmail.com Facebook: @thepsychedelicinvestor Music: www.bensound.com https://benzinga.grsm.io/jameshallifax1834 https://benzinga.grsm.io/thepsychedelicinvestor DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change. #MindMed #MNMD #MindMedstock
Kristen Bell Used Psychedelics to Treat Depression

Actress Kristen Bell Used Psychedelic Mushrooms to Treat Depression

Actress Kristen Bell says psychedelic mushrooms have helped her to treat her depression and anxiety symptoms.
Shark Tank’s Kevin O’Leary Deep Dives Into Psychedelics

Shark Tank’s Kevin O’Leary Deep Dives Into Psychedelics

Shark Tank investor Kevin O'Leary is a big fan of psychedelics. Here's everything you need to know.